{
    "id": 32317,
    "fullName": "TYK2 E957D",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "TYK2 E957D lies within the protein kinase domain 2 of the Tyk2 protein (UniProt.org). E957D confers a gain of function to the Tyk2 protein as demonstrated by ligand-independent phosphorylation of Tyk2, Stat1/3/5, and Erk1/2 and transformation of cultured cells (PMID: 23471820).",
            "references": [
                {
                    "id": 17688,
                    "pubMedId": 23471820,
                    "title": "TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23471820"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7297,
        "geneSymbol": "TYK2",
        "terms": [
            "TYK2",
            "IMD35",
            "JTK1"
        ]
    },
    "variant": "E957D",
    "createDate": "01/28/2020",
    "updateDate": "01/29/2020",
    "referenceTranscriptCoordinates": {
        "id": 187143,
        "transcript": "NM_003331",
        "gDna": "chr19:g.10354079C>G",
        "cDna": "c.2871G>C",
        "protein": "p.E957D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 21278,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Pyridone 6 (CMP6) inhibited proliferation of transformed mouse Ba/F3 cells expressing TYK2 E957D in culture (PMID: 23471820).",
            "molecularProfile": {
                "id": 34834,
                "profileName": "TYK2 E957D"
            },
            "therapy": {
                "id": 2797,
                "therapyName": "Pyridone 6",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17688,
                    "pubMedId": 23471820,
                    "title": "TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23471820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 21277,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, T-cell acute lymphoblastic leukemia cells harboring a JAK1 nonsense mutation and TYK2 E957D demonstrated resistance to Xeljanz (tofacitinib) in culture (PMID: 23471820).",
            "molecularProfile": {
                "id": 36165,
                "profileName": "JAK1 inact mut TYK2 E957D"
            },
            "therapy": {
                "id": 941,
                "therapyName": "Tofacitinib",
                "synonyms": null
            },
            "indication": {
                "id": 5603,
                "name": "T-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 17688,
                    "pubMedId": 23471820,
                    "title": "TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23471820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 21276,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Pyridone 6 (CMP6) inhibited proliferation of T-cell acute lymphoblastic leukemia cells harboring a JAK1 nonsense mutation and TYK2 E957D in culture (PMID: 23471820).",
            "molecularProfile": {
                "id": 36165,
                "profileName": "JAK1 inact mut TYK2 E957D"
            },
            "therapy": {
                "id": 2797,
                "therapyName": "Pyridone 6",
                "synonyms": null
            },
            "indication": {
                "id": 5603,
                "name": "T-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17688,
                    "pubMedId": 23471820,
                    "title": "TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23471820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 21275,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tyrphostin B42 (AG-490) inhibited proliferation of T-cell acute lymphoblastic leukemia cells harboring a JAK1 nonsense mutation and TYK2 E957D in culture (PMID: 23471820).",
            "molecularProfile": {
                "id": 36165,
                "profileName": "JAK1 inact mut TYK2 E957D"
            },
            "therapy": {
                "id": 2783,
                "therapyName": "Tyrphostin B42",
                "synonyms": null
            },
            "indication": {
                "id": 5603,
                "name": "T-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17688,
                    "pubMedId": 23471820,
                    "title": "TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23471820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34834,
            "profileName": "TYK2 E957D",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 36165,
            "profileName": "JAK1 inact mut TYK2 E957D",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 187142,
            "transcript": "XM_011528245",
            "gDna": "chr19:g.10354079C>G",
            "cDna": "c.2871G>C",
            "protein": "p.E957D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 187143,
            "transcript": "NM_003331",
            "gDna": "chr19:g.10354079C>G",
            "cDna": "c.2871G>C",
            "protein": "p.E957D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}